The Pharmaletter
One To Watch
DiCE Molecules
DiCE Molecules is a privately held biotechnology company using directed evolution to power small molecule drug discovery.
DiCE was co-founded in 2013 by Pehr Harbury, the investor of the firm's core technology, Kevin Judice and Phil Patten.
Latest DiCE Molecules News
11 January 2021
20 December 2017
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze